Sign In
Buy GMAB
$23.88
+0.0300 (+0.126%)
At Close: Jun 03, 2026
Genmab: Monoclonal Antibody Experts, Low Risk Business Model
10:59pm, Tuesday, 17'th Aug 2021
Genmab: Monoclonal Antibody Experts, Low Risk Business Model
Capital Increase in Genmab as a Result of Employee Warrant Exercise
02:51pm, Tuesday, 17'th Aug 2021
Company Announcement
Genmab A/S (GMAB) CEO Jan van de Winkel on Q2 2021 Results - Earnings Call Transcript
04:27pm, Wednesday, 11'th Aug 2021
Genmab A/S (GMAB) CEO Jan van de Winkel on Q2 2021 Results - Earnings Call Transcript
Is a Surprise Coming for Genmab (GMAB) This Earnings Season?
10:04am, Monday, 09'th Aug 2021
Genmab (GMAB) is seeing favorable earnings estimate revision activity and has a positive Zacks Earnings ESP heading into earnings season.
Capital Increase in Genmab as a Result of Employee Warrant Exercise
02:04pm, Tuesday, 06'th Jul 2021
Company Announcement
ALXN or GMAB: Which Is the Better Value Stock Right Now?
12:47pm, Monday, 05'th Jul 2021
ALXN vs. GMAB: Which Stock Is the Better Value Option?
Completion of share buy-back program
03:42am, Thursday, 01'st Jul 2021
Company Announcement
Transactions in connection with share buy-back program
03:30am, Monday, 28'th Jun 2021
Company Announcement
Grant of Restricted Stock Units and Warrants to Employees in Genmab
04:16pm, Tuesday, 22'nd Jun 2021
Company Announcement
Transactions in connection with share buy-back program
03:46am, Monday, 21'st Jun 2021
Company Announcement
Transactions with shares and linked securities in Genmab A/S made by managerial employees and their closely associated persons
07:12pm, Tuesday, 15'th Jun 2021
Company Announcement
Transactions in connection with share buy-back program
03:57am, Monday, 14'th Jun 2021
Company Announcement
Transactions in connection with share buy-back program
04:01am, Monday, 07'th Jun 2021
Company Announcement
